December 2018 Briefing - Pharmacy

Share this content:

Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

New Guidelines Address Care for Malignant Pleural Effusions

FRIDAY, Dec. 28, 2018 (HealthDay News) -- New clinical practice guidelines for the management of malignant pleural effusions were published in the January issue of the Annals of the American Thoracic Society.

Abstract/Full Text (subscription or payment may be required)

Second-Line Antidiabetic Meds May Impact Cardiovascular Risk

FRIDAY, Dec. 28, 2018 (HealthDay News) -- For adults with type 2 diabetes initiating second-line antidiabetic medications (ADM), cardiovascular risk is increased with use of sulfonylureas or basal insulin versus newer ADM classes, according to a study published online Dec. 21 in JAMA Network Open.

Abstract/Full Text
Editorial

ACOG Updates Guidelines for Gestational HTN, Preeclampsia

FRIDAY, Dec. 28, 2018 (HealthDay News) -- The American College of Obstetricians & Gynecologists (ACOG) has updated its guidance on the management of gestational hypertension and preeclampsia as well as chronic hypertension in pregnant women; the two practice bulletins were published in the January issue of Obstetrics & Gynecology.

Gestational Hypertension and Preeclampsia
Chronic Hypertension in Pregnancy

Effect Sizes Uncertain for Meds Versus Placebo in Knee OA

FRIDAY, Dec. 28, 2018 (HealthDay News) -- For patients with knee osteoarthritis and at least 12 months of follow-up, there is uncertainty around estimates of effect size for the change in pain in association with medications versus placebo, according to a meta-analysis published in the Dec. 25 issue of the Journal of the American Medical Association.

Abstract/Full Text (subscription or payment may be required)

Review Highlights Lack of Tx Options for Prurigo Nodularis

FRIDAY, Dec. 28, 2018 (HealthDay News) -- A new review, published in the Journal of the American Academy of Dermatology, provides evidence-based guidance for practitioners treating the dermatologic condition prurigo nodularis and highlights gaps in treatment development and research.

Abstract/Full Text (subscription or payment may be required)

Low-Priced Generic Drugs Most Likely to Have Shortages

THURSDAY, Dec. 27, 2018 (HealthDay News) -- The lowest-priced generic drugs are more likely to experience shortages, according to a study published in the November issue of Value in Health.

Abstract/Full Text (subscription or payment may be required)

More Than Two-Thirds of Drug OD Deaths in 2017 Involved Opioids

THURSDAY, Dec. 27, 2018 (HealthDay News) -- More than two-thirds of drug overdose deaths in 2017 involved an opioid, with increases in overdose deaths from all opioids and synthetic opioids seen from 2016 to 2017, according to research published in the Dec. 21 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Abstract/Full Text

Opioid Prescribing Patterns Vary for Pediatric Patients

THURSDAY, Dec. 27, 2018 (HealthDay News) -- There is considerable variation in opioid prescribing among pediatric patients, according to a study published online Dec. 21 in JAMA Network Open.

Abstract/Full Text

ASH Develops Practice Guidelines for Venous Thromboembolism

THURSDAY, Dec. 27, 2018 (HealthDay News) -- The American Society of Hematology (ASH) has developed new guidelines for the treatment of venous thromboembolism (VTE); the clinical practice guidelines were recently published in Blood Advances.

Prophylaxis for Hospitalized and Nonhospitalized Medical Patients
Diagnosis of Venous Thromboembolism
Heparin-Induced Thrombocytopenia
Treatment of Pediatric Venous Thromboembolism
Venous Thromboembolism in the Context of Pregnancy
Optimal Management of Anticoagulation Therapy

Complications, Costs Up With Cardiac Sx in Opioid Use Disorder

WEDNESDAY, Dec. 26, 2018 (HealthDay News) -- Patients with opioid use disorder (OUD) undergoing cardiac surgery have increased complications and costs, according to a study published online Dec. 5 in JAMA Surgery.

Abstract/Full Text (subscription or payment may be required)

Updated Guidelines Developed for Diagnosing, Treating Influenza

WEDNESDAY, Dec. 26, 2018 (HealthDay News) -- The Infectious Diseases Society of America has updated their recommendations for the care of patients with suspected or diagnosed influenza; the clinical practice guidelines were published online Dec. 19 in Clinical Infectious Diseases.

Abstract/Full Text

New AAP Guideline Available for Infantile Hemangioma Treatment

WEDNESDAY, Dec. 26, 2018 (HealthDay News) -- The American Academy of Pediatrics has developed its first guideline for the management of infantile hemangiomas (IHs); the clinical practice guideline was published online Dec. 24 in Pediatrics.

Abstract/Full Text

FDA Approves Drugs for Treatment of Two Rare Blood Diseases

MONDAY, Dec. 24, 2018 (HealthDay News) -- Two drugs have been approved by the U.S. Food and Drug Administration for the treatment of rare blood diseases, the agency announced Friday.

More Information - Elzonris
More Information - Ultomiris

Vit C for Pregnant Smokers May Improve Newborn Lung Function

MONDAY, Dec. 24, 2018 (HealthDay News) -- For pregnant smokers, vitamin C supplementation may improve newborn lung function, according to a study published online Dec. 7 in the American Journal of Respiratory and Critical Care Medicine.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Incorrect Prescribing Alerts Common for Psychotropic Meds

FRIDAY, Dec. 21, 2018 (HealthDay News) -- Incorrect prescribing alerts for psychotropic medications may be common, according to a study published online Dec. 4 in the Journal of Clinical Psychiatry.

Abstract/Full Text

FDA: Fluoroquinolones Tied to Heart Vessel Ruptures, Tears

FRIDAY, Dec. 21, 2016 (HealthDay News) -- Patients taking fluoroquinolones may be at higher risk for ruptures or tears in the aorta, the U.S. Food and Drug Administration warns.

More Information

FDA: Teething Jewelry Linked to at Least One Infant Death

FRIDAY, Dec. 21, 2018 (HealthDay News) -- Teething jewelry products, such as necklaces, pose significant safety risks and have been tied to at least one baby's death, the U.S. Food and Drug Administration warns.

More Information

A-Fib Risk Up for Antidepressant Users, but Higher Before Tx

FRIDAY, Dec. 21, 2018 (HealthDay News) -- The risk for atrial fibrillation (AF) is increased among antidepressant users, particularly before treatment initiation, according to a study recently published in the European Journal of Preventive Cardiology.

Abstract/Full Text

Racial Disparities Seen in Use of Oral Anticoagulants for A-Fib

THURSDAY, Dec. 20, 2018 (HealthDay News) -- Black patients with atrial fibrillation are less likely to receive direct-acting oral anticoagulants (DOACs) compared with white patients, even after controlling for clinical and sociodemographic features, according to a study published in the December issue of JAMA Cardiology.

Abstract/Full Text

Prevalence of Benzodiazepine Use 12.6 Percent in the United States

THURSDAY, Dec. 20, 2018 (HealthDay News) -- Overall, 12.6 percent of U.S. adults report past-year benzodiazepine use, with misuse accounting for 17.2 percent of overall use, according to a study published online Dec. 17 in Psychiatric Services.

Abstract/Full Text (subscription or payment may be required)

CDC: ~65 Percent of U.S. Women Currently Using Contraceptives

THURSDAY, Dec. 20, 2018 (HealthDay News) -- Almost two-thirds of U.S. women aged 15 to 49 years were currently using contraception in 2015 to 2017, according to a December data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.

Abstract/Full Text

Affordable Care Act Sign-Ups Higher Than Expected

THURSDAY, Dec. 20, 2018 (HealthDay News) -- Despite numerous difficulties, early figures show that sign-ups for health coverage next year under the Affordable Care Act are higher than expected.

AP News Article

Sorafenib for Desmoid Tumors Ups Progression-Free Survival

THURSDAY, Dec. 20, 2018 (HealthDay News) -- Sorafenib prolongs progression-free survival among patients with desmoid tumors, according to a study published in the Dec. 20 issue of the New England Journal of Medicine.

Abstract/Full Text (subscription or payment may be required)

ADA 2019 Standards of Care Emphasize Patient-Centered Care

THURSDAY, Dec. 20, 2018 (HealthDay News) -- Patient-centered care is emphasized in updated clinical practice recommendations from the American Diabetes Association 2019 Standards of Care, published as a supplement to the January issue of Diabetes Care.

More Information

Pembrolizumab Promising for Metastatic Head, Neck SCC

THURSDAY, Dec. 20, 2018 (HealthDay News) -- For patients with recurrent or metastatic head and neck squamous cell carcinoma, pembrolizumab has a favorable safety profile and is associated with prolongation of overall survival, according to a study published online Nov. 30 in The Lancet.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Hospitalization for Upper GI Bleed Highest With Rivaroxaban

THURSDAY, Dec. 20, 2018 (HealthDay News) -- For patients initiating oral anticoagulant therapy, the incidence of hospitalization for upper gastrointestinal bleeding is highest and lowest with rivaroxaban and apixaban, respectively, according to a study published in the Dec. 4 issue of the Journal of the American Medical Association.

Abstract/Full Text (subscription or payment may be required)

Modified-FOLFIRINOX Beneficial in Resected Pancreatic Cancer

WEDNESDAY, Dec. 19, 2018 (HealthDay News) -- For patients with resected pancreatic cancer, adjuvant therapy with a modified regimen of chemotherapy with fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX), compared with gemcitabine, results in significantly longer survival, according to a study published in the Dec. 20 issue of the New England Journal of Medicine.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

FDA Advisory Panels: Prescribe Naloxone With Opioid Painkillers

WEDNESDAY, Dec. 19, 2018 (HealthDay News) -- The labels of prescription opioid painkillers should advise doctors to consider simultaneously prescribing the opioid overdose antidote naloxone, two U.S. Food and Drug Administration advisory panels recommend.

Washington Post Article

Postmenopausal Vaginal Estrogen Not Tied to Negative Health Outcomes

WEDNESDAY, Dec. 19, 2018 (HealthDay News) -- For postmenopausal women, vaginal estrogen use is not associated with negative health outcomes, according to a study published online Dec. 17 in Menopause.

Abstract/Full Text (subscription or payment may be required)

Cardiac Malformations Not Up With First-Trimester Ondansetron

WEDNESDAY, Dec. 19, 2018 (HealthDay News) -- First-trimester ondansetron use is associated with a small increased risk for oral cleft but no increased risk for congenital malformations or cardiac malformations, according to a study published in the Dec. 18 issue of the Journal of the American Medical Association.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Failure of Timely Stop to Certain Prescription Drugs Is Common

WEDNESDAY, Dec. 19, 2018 (HealthDay News) -- Legacy prescribing of certain drugs, such as antidepressants and proton pump inhibitors (PPIs), is common, according to a study published in the November/December issue of the Annals of Family Medicine.

Abstract/Full Text

Opioids Offer Small Improvement in Pain, Physical Function

TUESDAY, Dec. 18, 2018 (HealthDay News) -- Opioid use is associated with small improvements in pain and physical functioning in patients with chronic noncancer pain, according to research published in the Dec. 18 issue of the Journal of the American Medical Association.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Chest CT Can ID Respiratory AE Risk in RA Patients on Biologics

TUESDAY, Dec. 18, 2018 (HealthDay News) -- Chest computed tomography (CT) findings may identify risk factors for respiratory adverse events (RAEs) in rheumatoid arthritis (RA) patients undergoing long-term biological therapy, according to a study recently published in the International Journal of Rheumatic Diseases.

Abstract/Full Text (subscription or payment may be required)

Routine Supplements to Prevent Chronic Disease Not Advised

TUESDAY, Dec. 18, 2018 (HealthDay News) -- Routine use of vitamin and mineral supplements to prevent chronic disease is not recommended, according to an Academy of Nutrition and Dietetics position paper published in the November issue of the Journal of the Academy of Nutrition and Dietetics.

Abstract/Full Text

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

MONDAY, Dec. 17, 2018 (HealthDay News) -- Buprenorphine-naloxone is cost-effective compared with extended-release naltrexone for treating opioid use disorder, according to a study published online Dec. 18 in the Annals of Internal Medicine.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Adherence and Intensity of Lipid-Lowering Tx Influence CV Risk

MONDAY, Dec. 17, 2018 (HealthDay News) -- Adherent patients receiving high-intensity statin and/or ezetimibe therapy have the lowest cardiovascular risk, according to a study published online Dec. 7 in JAMA Network Open.

Abstract/Full Text

Barbershop Intervention Leads to Reduced BP in Black Men

MONDAY, Dec. 17, 2018 (HealthDay News) -- A barbershop-based intervention can lead to significantly reduced blood pressure and sustained improvements over one year in black men, according to a study published online Dec. 17 in Circulation.

Abstract/Full Text

Solriamfetol Feasible for Sleep Apnea-Related Tiredness

MONDAY, Dec. 17, 2018 (HealthDay News) -- Solriamfetol therapy, compared with placebo, results in improvements in wakefulness and sleepiness measures in patients with excessive sleepiness due to obstructive sleep apnea (OSA), according to a study published online Dec. 6 in the American Journal of Respiratory and Critical Care Medicine.

Abstract/Full Text (subscription or payment may be required)

Some With Type 2 Diabetes Inappropriately Monitoring Blood Glucose

MONDAY, Dec. 17, 2018 (HealthDay News) -- A considerable proportion of patients with type 2 diabetes may be self-monitoring blood glucose inappropriately, according to a research letter published online Dec. 10 in JAMA Internal Medicine.

Abstract/Full Text (subscription or payment may be required)

Cisplatin Superior to Cetuximab for HPV+ Oropharyngeal Cancer

MONDAY, Dec. 17, 2018 (HealthDay News) -- For treatment of human papillomavirus (HPV)-positive low-risk oropharyngeal cancer, cetuximab shows no benefit compared with the standard cisplatin regimen in terms of reduced toxicity and results in worse tumor control, according to a study recently published in The Lancet.

Abstract/Full Text

Phone-Based Intervention Aids Rheumatoid Arthritis Care

FRIDAY, Dec. 14, 2018 (HealthDay News) -- A nurse-based phone education intervention can promote shared decision making in patients with newly diagnosed rheumatoid arthritis (RA), according to a study published online Dec. 5 in Musculoskeletal Care.

Abstract/Full Text (subscription or payment may be required)

Apixaban Prevents VTE in Cancer Patients Initiating Chemotherapy

FRIDAY, Dec. 14, 2018 (HealthDay News) -- Among patients with cancer starting chemotherapy who are at intermediate-to-high risk, rates of venous thromboembolism are significantly lower for thromboprophylaxis with apixaban versus placebo, according to a study published online Dec. 4 in the New England Journal of Medicine.

Abstract/Full Text (subscription or payment may be required)

Guidelines Developed for Opioid Use in Vaginal Birth

FRIDAY, Dec. 14, 2018 (HealthDay News) -- Guidelines have been developed for use of opioids for uncomplicated spontaneous vaginal birth; the draft consensus guidelines were published online Dec. 4 in Obstetrics & Gynecology.

Abstract/Full Text (subscription or payment may be required)

Medication Beliefs Affect Uptake of Preventive Tx for Breast Cancer

FRIDAY, Dec. 14, 2018 (HealthDay News) -- Beliefs about medication are associated with uptake of tamoxifen as a preventive therapy among women at increased risk for breast cancer, according to a study published online Dec. 2 in Clinical Breast Cancer.

Abstract/Full Text

Racial Disparities Seen Among Teens Undergoing Flu Vaccination

FRIDAY, Dec. 14, 2018 (HealthDay News) -- Racial disparities exist among adolescents undergoing influenza vaccination, with lower odds of vaccination among black versus white adolescents, according to a study recently published in Public Health Reports.

Abstract/Full Text

EHR-Linked Reminder System for Glaucoma Meds Perceived Useful

FRIDAY, Dec. 14, 2018 (HealthDay News) -- Patients with glaucoma generally find an electronic health record (EHR)-linked reminder system for glaucoma medications useful, according to a study published online Dec. 13 in JAMA Ophthalmology.

Abstract/Full Text
Editorial (subscription or payment may be required)

Medication Errors Resulting in Death Most Common in Elderly

THURSDAY, Dec. 13, 2018 (HealthDay News) -- Medication errors in acute care that result in death occur most often in patients older than 75 years, with the most common error category being omitted medicine or ingredient, according to a study published online Nov. 22 in Research in Social and Administrative Pharmacy.

Abstract/Full Text

FDA: Some E-Cigarette Liquids Contain Erectile Dysfunction Meds

WEDNESDAY, Dec. 12, 2018 (HealthDay News) -- Consumers should not use two electronic cigarette liquids that contain erectile dysfunction drugs because they may pose health risks, according to the U.S. Food and Drug Administration.

More Information

Recalled Kotex Tampons Can Unravel Inside Body

WEDNESDAY, Dec. 12, 2018 (HealthDay News) -- Certain Kotex tampons are being recalled by Kimberly-Clark because they can unravel and leave pieces inside women's bodies.

CBS News Article
FDA Safety Alert

Enrollment Under the Affordable Care Act Down From Last Year

WEDNESDAY, Dec. 12, 2018 (HealthDay News) -- Enrollment for health insurance under the Affordable Care Act is down with just days left to sign up, according to the U.S. Centers for Medicare & Medicaid Services.

AP News Article

Antipsychotics Up Risk for Unexpected Death in Youths

WEDNESDAY, Dec. 12, 2018 (HealthDay News) -- Antipsychotic use is associated with an increased risk for unexpected death among children and youths, according to a study published online Dec. 12 in JAMA Psychiatry.

Abstract/Full Text
Editorial (subscription or payment may be required)

2017 Saw Slowing in National Health Care Spending

WEDNESDAY, Dec. 12, 2018 (HealthDay News) -- National health care spending slowed in 2017, according to a report published online Dec. 6 in Health Affairs.

Abstract/Full Text (subscription or payment may be required)

CDC Identifies Drugs Frequently Involved in Drug Overdose Deaths

WEDNESDAY, Dec. 12, 2018 (HealthDay News) -- The drugs most commonly involved in drug overdose deaths during 2011 to 2016 include fentanyl, heroin, oxycodone, and cocaine, according to the Dec. 12 issue of the National Vital Statistics Reports, a publication from the U.S. Centers for Disease Control and Prevention.

Abstract/Full Text

Patients May Become Immune to Botulinum Toxin Treatments

TUESDAY, Dec. 11, 2018 (HealthDay News) -- About 15 percent of patients treated with botulinum toxin type A (BoNT/A) for dystonia or spasticity can develop an immune response to the treatment itself, according to a study published online Nov. 21 in Neurology.

Abstract/Full Text (subscription or payment may be required)

Consensus Decision Pathway Developed for Tobacco Cessation

TUESDAY, Dec. 11, 2018 (HealthDay News) -- An expert consensus decision pathway has been developed for tobacco cessation treatment; the report was published online Dec. 5 in the Journal of the American College of Cardiology.

Abstract/Full Text

Reference Infliximab, Biosimilar Equivalent for Crohn's Disease

TUESDAY, Dec. 11, 2018 (HealthDay News) -- CT-P13, which is a biosimilar of the reference product (RP) infliximab, has equivalent effectiveness for infliximab-naive patients with Crohn's disease (CD), according to a study published online Dec. 11 in the Annals of Internal Medicine.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

AHA Scientific Statement: Low Risk of Side Effects for Statins

MONDAY, Dec. 10, 2018 (HealthDay News) -- Statins are associated with a low risk for side effects, according to a scientific statement from the American Heart Association (AHA) published online Dec. 10 in Arteriosclerosis, Thrombosis and Vascular Biology.

Abstract/Full Text

Smaller Heads Related to Opioid-Related Neonatal Abstinence Syndrome

MONDAY, Dec. 10, 2018 (HealthDay News) -- Chronic opioid use during pregnancy that causes neonatal abstinence syndrome (NAS) is associated with smaller neonatal head circumference (HC), according to a study published online Dec. 10 in Pediatrics.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

PM2.5 Exposure Linked to Asthma Rescue Medication Use

MONDAY, Dec. 10, 2018 (HealthDay News) -- For individuals with asthma, increased fine particulate matter (PM2.5) exposure is associated with increased weekly rescue inhaler use, according to a study published online Nov. 26 in the Proceedings of the National Academy of Sciences.

Abstract/Full Text

Fear Impacts Quality of Life for Young Adults With Type 1 Diabetes

FRIDAY, Dec. 7, 2018 (HealthDay News) -- Fear of complications and frustration at the amount of time required to manage type 1 diabetes impact the quality of life of young adults with the disease, according to a study published in the December issue of The Diabetes Educator.

Abstract/Full Text

Ultrarestrictive Opioid Rx Protocol Cuts Postoperative Opioid Use

FRIDAY, Dec. 7, 2018 (HealthDay News) -- An ultrarestrictive opioid prescription protocol (UROPP) can reduce the number of opioids prescribed to patients after gynecologic and abdominal surgery without negative health consequences, according to a study published online Dec. 7 in JAMA Network Open.

Abstract/Full Text
Editorial

Botox Injections Explored to Cut Postop A-Fib in Cardiac Surgery

FRIDAY, Dec. 7, 2018 (HealthDay News) -- Intraoperative botulinum toxin (BTX) injections show promise as a way to reduce the risk for postoperative atrial fibrillation (AF) following cardiac surgery, according to two studies recently published in Heart Rhythm.

Abstract/Full Text - Romanov (subscription or payment may be required)
Abstract/Full Text - Waldron (subscription or payment may be required)
Editorial (subscription or payment may be required)

Meds Taken Do Not Vary With ADL Impairment in Heart Failure

FRIDAY, Dec. 7, 2018 (HealthDay News) -- For individuals with heart failure, those with impairment in activities of daily living (ADL) take as many medications as those without ADL impairment, according to a study published online Nov. 29 in the Journal of the American Geriatrics Society.

Abstract/Full Text (subscription or payment may be required)

Pregnant Women Commonly Refuse Vaccines

FRIDAY, Dec. 7, 2018 (HealthDay News) -- Pregnant women commonly refuse vaccines, including influenza vaccine and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine, according to research published online Dec. 4 in Obstetrics & Gynecology.

Abstract/Full Text (subscription or payment may be required)

Many Americans Unaware of Promise of Personalized Medicine

THURSDAY, Dec. 6, 2018 (HealthDay News) -- Medical science has made tremendous advances in personalized medicine. However, the American public is still struggling to understand the implications of these targeted treatments, a new HealthDay/Harris Poll has revealed.

HealthDay Article

Recommendations Developed for Psoriatic Arthritis Treatment

THURSDAY, Dec. 6, 2018 (HealthDay News) -- Recommendations have been developed for pharmacologic and nonpharmacologic treatment of psoriatic arthritis (PsA); the evidence-based guideline was published online Nov. 30 in Arthritis & Rheumatology.

Abstract/Full Text

Opioids Overprescribed After Arthroscopic Meniscectomy

THURSDAY, Dec. 6, 2018 (HealthDay News) -- Prescription opioid medications are overprescribed after simple arthroscopic meniscectomy, according to a study recently published in The Journal of Bone & Joint Surgery.

Abstract/Full Text (subscription or payment may be required)

FDA Warns of Rare Stroke Risk With Multiple Sclerosis Drug

WEDNESDAY, Dec. 5, 2018 (HealthDay News) -- A new warning has been added to the multiple sclerosis drug Lemtrada (alemtuzumab) after rare reports of patients suffering strokes and tears in the lining of the arteries in the head and neck, the U.S. Food and Drug Administration said.

More Information

Infections Linked to Increased Later Risk for Mental Disorders

WEDNESDAY, Dec. 5, 2018 (HealthDay News) -- Infections requiring hospitalization or treatment with anti-infective agents are associated with an increased subsequent risk for mental disorders, according to a study published online Dec. 5 in JAMA Psychiatry.

Abstract/Full Text
Editorial (subscription or payment may be required)

Exposure to Phthalates May Impact Timing of Puberty in Girls

TUESDAY, Dec. 4, 2018 (HealthDay News) -- Exposure to certain endocrine-disrupting chemicals may impact the timing of puberty in children, according to a study published online Dec. 4 in Human Reproduction.

Abstract/Full Text (subscription or payment may be required)

HHS Issues Draft Strategy for Reducing Health IT Burden

TUESDAY, Dec. 4, 2018 (HealthDay News) -- The U.S. Department of Health and Human Services has developed a draft strategy to reduce the health information technology (IT) burden, and the strategy is open for public comment through Jan. 28, 2019.

More Information

Urate Elevation in Potential Tx for Parkinson's Not Tied to HTN

TUESDAY, Dec. 4, 2018 (HealthDay News) -- There is no correlation between urate and blood pressure (BP) in mice or among patients with early Parkinson's disease (PD), according to a study published in the November issue of EBioMedicine.

Abstract/Full Text

Mean Cumulative Lifetime Prevalence of Eczema 9.9 Percent

TUESDAY, Dec. 4, 2018 (HealthDay News) -- The mean cumulative lifetime prevalence of atopic eczema is 9.9 percent, according to a research letter published online Dec. 4 in the Annals of Internal Medicine.

Abstract/Full Text (subscription or payment may be required

Cost-Related Insulin Underuse May Affect One in Four Patients

MONDAY, Dec. 3, 2018 (HealthDay News) -- About one in four patients report cost-related insulin underuse, which is associated with poor glycemic control, according to a research letter published online Dec. 3 in JAMA Internal Medicine.

Abstract/Full Text
Editorial

Prevalence of Ever-Diagnosed ASD 2.79 Percent in U.S. Children

MONDAY, Dec. 3, 2018 (HealthDay News) -- The prevalence of ever-diagnosed autism spectrum disorder (ASD) is 2.79 percent in the United States, with state-level variations in prevalence, according to a study published online Dec. 3 in JAMA Pediatrics.

Abstract/Full Text

More People Worldwide Now Know Their HIV Status

MONDAY, Dec. 3, 2018 (HealthDay News) -- Three-quarters of patients living with HIV worldwide know their infection status, according to Knowledge Is Power, a new report released Nov. 22 by UNAIDS.

Press Release
Knowledge Is Power Report

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »